Best Practices for Complying with Consumer Products Safety Commission Regulations
19 July 2023
Erik Swanholt is a partner and co-chair of Foley’s Consumer Products Team in Los Angeles. He works with manufacturers, distributors, and retailers to help clients navigate the complicated rules and regulations of the Consumer Product Safety Commission (CPSC). CPSC protects the public from unreasonable risks of serious injury or death by issuing and enforcing mandatory standards, requiring recalls of certain products and issuing civil penalties to companies that fail to comply with their duties. In this video, Erik talks about important strategies to stay CPSC compliant.
Key Takeaways
- Foley helps clients navigate the complicated rules and regulations of the Consumer Product Safety Commission or “CPSC.”
- The CPSC is the primary federal government regulator of consumer products in the U.S. and they focus on product safety.
- The CPSC’s stated purpose is to protect the public from unreasonable risks of serious injury or deaths from the thousands of consumer products under its jurisdiction
- Companies that manufacture, distribute or sell consumer products in the U.S. must comply with CPSC regulations and laws.
- The CPSC protects the public in a number of ways including by issuing and enforcing mandatory standards, requiring recalls of certain products, and issuing civil penalties to companies that fail to comply with their duties under the CPSC.
- Failure to comply can lead to recalls and civil penalties as well as potential follow-on litigation.
- Keys to CPSC compliance include (1) development of a plan to ensure your company manufactures, distributes and/or sells products that meet applicable safety standards and (2) having a plan to respond to reports from the field of consumer injuries from use of your products.
Disclaimer
This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.
Author(s)
Related Insights
07 November 2024
Manufacturing Industry Advisor
What Every Multinational Company Should Know About . . . Dawn Raids
In today’s regulatory landscape, dawn raids — surprise, on-the-spot government inspections — have become increasingly prevalent, especially in Europe, Asia, and South America, where regulatory scrutiny is intensifying.
05 November 2024
Health Care Law Today
Cancer Drugs: Clinical Trial Issues for Antibody Drug Conjugates (ADCs)/Antibody Therapeutics
Antibody Drug Conjugates (ADCs) are a class of small molecule drugs and an antibody conjugated together by a chemical linker.
05 November 2024
Health Care Law Today
New HCPCS for Advanced Primary Care Management
The Center for Medicare & Medicaid Services issued the display copy of the final Calendar Year 2025 Physician Fee Schedule on November 1, 2024, which included three new Healthcare Common Procedure Coding System codes for advanced primary care management.